Fundraising Fox

GLO Pharma

Encinitas, US · Founded 2018 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

SG
Scott GlennNamed on SEC filing

Board

JM
Jana MessersmithBoard director
LO
Lauren OtsukiBoard director
TJ
Todd JacksonBoard director

Investors · 1

Lightspeed Venture PartnersMenlo Park · $1.7M – $87M

Reported raises · per SEC filings

Form D private placements

$60.4M disclosed across 3 rounds · 2020–2021

▶$53MraisedSep 2023 · 189 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dayna QuanbeckDirector
  • Nicole QuinnDirector
  • Marla BeckDirector
  • Maureen CaseDirector
  • Fabian SeelbachDirector
  • Douglas WallDirector
  • Lauren OtsukiDirector, Executive Officer
  • Vimla Black-GuptaExecutive Officer, Director
Offering amount
$53M
Amount sold
$53M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.8MraisedNov 2020 · 20 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jana MessersmithDirector
  • Lauren OtsukiDirector
  • Scott GlennExecutive Officer, Director
  • Todd JacksonDirector
Offering amount
$6.8M
Amount sold
$6.8M
First sale
Nov 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$511KraisedNov 2020 · 22 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott GlennExecutive Officer, Director
  • Jana MessersmithDirector
  • Todd JacksonDirector
  • Lauren OtsukiDirector
Offering amount
$511K
Amount sold
$511K
First sale
Nov 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

GLO PHARMA PROMOTES FORMER ESTEE LAUDER AND PROCTER & GAMBLE BEAUTY EXECUTIVE, VIMLA BLACK-GUPTA, TO CEO OF OURSELFprnewswire.com · Aug 2022GLO Pharma locks in $30mventurecapitaljournal.com · Feb 2022OURSELF, THE FIRST-EVER SUBTOPICAL SKINCARE SYSTEM™, LAUNCHES TO PROVIDE CLINICAL-LEVEL RESULTS WITHOUT THE CLINICprnewswire.com · Feb 2022

Frequently asked questions

Who are GLO Pharma's investors?
GLO Pharma's investors include Lightspeed Venture Partners.
How much funding has GLO Pharma raised?
GLO Pharma has disclosed $60.4M raised across 3 rounds.
Where is GLO Pharma headquartered?
GLO Pharma is headquartered in Encinitas, US.